of Changes in the Geographical Distribution of Opioid- Related
Mortality Across the United States by Opioid Type, 1999-2016 read more
Deprescribing: A simple method for reducing polypharmacy Polypharmacy brings with it increased risks for adverse drug events and reduced functional capacity. This 4-step plan will help you safely deprescribe in older adults. read more
New Hampshire House passes bill allowing pharmacists to prescribe contraceptives read more
The Deadly Counterfeit Drug Trade Thrives in New Hampshire. read more
Social Media Sites: The New Wild West for Illegal Online Pharmacies read more
A Prescriber’s Guide to the New Medicare Part D Opioid OverutilizationPolicy for 2019read more
National Institute of Health 2018 New Hampshire Report read more
A message from the NH Department of Health and Human Services (DHHS)
Pharmacy Organizations Support National Standards for Technician Education - Read More
Effective January 1, 2019
SB 376 requires all pharmacies in New Hampshire that sell over the counter pseudoephedrine (PSE)/ephedrine (EPH) products to participate in NPLEx, which provides real time PSE electronic tracking in accordance with the Combat Methamphetamine Epidemic Act (CMEA).NPLEx is provided FREE of charge. Click Here for full info
FDA declares youth vaping epidemic, announces investigation, new enforcement.read more
Blood Pressure Recall expands again to include losartan read more
APhA Continues to Fight for Pharmacists’ Services in Federal Legislation
though many of you answered APhA’s calls for support and outreach, the
opioid bill passed by Congress and signed into law by President Trump
did not include any Medicare Part B coverage of pharmacists’
opioid-related services. During the development of
this year’s opioid legislative package, congressional leadership made
it clear that they would exclude measures having a significant budget
implication and therefore, the potential cost or score had been the
major barrier to the inclusion of pharmacists’ services language. While
we are admittedly extremely disappointed, our work was not in vain.
There is a better awareness and understanding in Congress and federal
agencies regarding the broad range of services—including those related
to pain management and substance use disorders— that pharmacists can
provide, and more appreciation for their value.
wants to reiterate our thanks and appreciation to the thousands of you
who reached out to your legislators asking for the passage of H.R.
592/S. 109, the Pharmacy and Medically Underserved Areas Enhancement Act and for related language to be added in opioid legislation.
lack of congressional passage is not indicative of the value of our
profession’s efforts nor of APhA’s efforts to inform legislators and the
Administration of the importance of covering pharmacists’ services. The
estimated cost of expanding patient access to pharmacists’ services has
always been a concern of Members of Congress.
The mission of the New Hampshire Pharmacists
Association is to promote, enhance, and advance
pharmacy practice, in the State of New Hampshire by advocating for the
professional interests of pharmacists, pharmacy technicians, student
pharmacists, and ancillary pharmacy personnel as well as to advocate for the
health and welfare of the general public.